S. Thureau

2.0k total citations
121 papers, 1.2k citations indexed

About

S. Thureau is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, S. Thureau has authored 121 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Radiology, Nuclear Medicine and Imaging, 55 papers in Pulmonary and Respiratory Medicine and 37 papers in Radiation. Recurrent topics in S. Thureau's work include Medical Imaging Techniques and Applications (45 papers), Advanced Radiotherapy Techniques (37 papers) and Lung Cancer Diagnosis and Treatment (36 papers). S. Thureau is often cited by papers focused on Medical Imaging Techniques and Applications (45 papers), Advanced Radiotherapy Techniques (37 papers) and Lung Cancer Diagnosis and Treatment (36 papers). S. Thureau collaborates with scholars based in France, China and Luxembourg. S. Thureau's co-authors include Pierre Véra, Romain Modzelewski, Bernard Dubray, Pierre Decazes, Isabelle Gardin, Pierre Michel, Sébastien Hapdey, B Paillot, Isabelle Iwanicki–Caron and David Tougeron and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

S. Thureau

104 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Thureau France 20 540 479 286 256 246 121 1.2k
Arturo Navarro-Martín Spain 19 323 0.6× 537 1.1× 196 0.7× 147 0.6× 325 1.3× 68 1.0k
Pranshu Mohindra United States 23 486 0.9× 754 1.6× 169 0.6× 458 1.8× 398 1.6× 128 1.5k
Colin Tang Australia 18 517 1.0× 910 1.9× 158 0.6× 589 2.3× 196 0.8× 65 1.4k
Patrizia Ciammella Italy 18 426 0.8× 770 1.6× 157 0.5× 546 2.1× 225 0.9× 84 1.3k
Zvi Symon Israel 21 362 0.7× 708 1.5× 377 1.3× 467 1.8× 439 1.8× 105 1.7k
Jesmin Shafiq Australia 17 827 1.5× 523 1.1× 263 0.9× 618 2.4× 512 2.1× 44 1.7k
Guila Delouya Canada 17 193 0.4× 498 1.0× 171 0.6× 261 1.0× 188 0.8× 102 1.1k
Daniel Taussky Canada 19 214 0.4× 860 1.8× 325 1.1× 460 1.8× 228 0.9× 133 1.3k
Ahmed Salem Jordan 19 277 0.5× 438 0.9× 197 0.7× 146 0.6× 280 1.1× 97 1.1k
Nikhil G. Thaker United States 17 244 0.5× 414 0.9× 222 0.8× 296 1.2× 173 0.7× 70 1.1k

Countries citing papers authored by S. Thureau

Since Specialization
Citations

This map shows the geographic impact of S. Thureau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Thureau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Thureau more than expected).

Fields of papers citing papers by S. Thureau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Thureau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Thureau. The network helps show where S. Thureau may publish in the future.

Co-authorship network of co-authors of S. Thureau

This figure shows the co-authorship network connecting the top 25 collaborators of S. Thureau. A scholar is included among the top collaborators of S. Thureau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Thureau. S. Thureau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tourneau, Christophe Le, Zoltán Takácsi‐Nagy, Sandra Nuyts, et al.. (2025). Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC. Future Oncology. 21(12). 1489–1499. 3 indexed citations
3.
Lucia, François, et al.. (2024). Role of stereotactic radiotherapy in the management of small-cell lung cancer. Cancer/Radiothérapie. 28(6-7). 628–632.
4.
Khalifa, Jonathan, Antonin Lévy, S. Thureau, et al.. (2023). Radiotherapy in the management of synchronous metastatic lung cancer. Cancer/Radiothérapie. 28(1). 22–35.
5.
Belkacémi, Yazid, D. Lerouge, C. Durdux, et al.. (2023). Revue de morbidité et mortalité en radiothérapie : procédure, implémentation et perspectives du projet national français « Proust ». Cancer/Radiothérapie. 27(6-7). 474–479.
6.
Henni, A. Hadj, et al.. (2023). ExacTrac X-Ray 6D Imaging During Stereotactic Body Radiation Therapy of Spinal and Nonspinal Metastases. Technology in Cancer Research & Treatment. 22. 2223952674–2223952674.
7.
Salleron, Julia, Guillaume Vogin, Pedro G. Teixeira, et al.. (2023). Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?. Cancer/Radiothérapie. 27(1). 1–10. 1 indexed citations
8.
Osman, David, R. de Crevoisier, C. Dejean, et al.. (2023). Enjeux éthiques de l’information en oncologie radiothérapie : penser le risque et construire l’alliance thérapeutique. Cancer/Radiothérapie. 27(6-7). 480–486.
11.
Decazes, Pierre, et al.. (2023). Advances in PET and MRI imaging of tumor hypoxia. Frontiers in Medicine. 10. 1055062–1055062. 21 indexed citations
12.
Salleron, Julia, Youlia Kirova, Christelle Lévy, et al.. (2022). Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-Study. Cancers. 14(16). 3928–3928. 6 indexed citations
14.
Thureau, S., Nicolas Piton, Romain Modzelewski, et al.. (2021). First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer. Cancers. 13(16). 4101–4101. 26 indexed citations
15.
Thureau, S., et al.. (2021). Radiotherapy of bone metastases. Cancer/Radiothérapie. 26(1-2). 368–376. 4 indexed citations
16.
Huguet, F., R. de Crevoisier, C. Dejean, et al.. (2021). Enjeux éthiques de la pratique des soins à visée palliative en oncologie radiothérapique. Cancer/Radiothérapie. 25(6-7). 699–706. 2 indexed citations
17.
Thureau, S., Justine Lequesne, Agathe Edet‐Sanson, et al.. (2020). Impact of the Bayesian penalized likelihood algorithm (Q.Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic images. EJNMMI Physics. 7(1). 28–28. 15 indexed citations
18.
Thariat, Juliette, Samuel Valable, Siamak Haghdoost, et al.. (2019). Hadrontherapy Interactions in Molecular and Cellular Biology. International Journal of Molecular Sciences. 21(1). 133–133. 21 indexed citations
19.
Padovani, Laëtitia, S. Thureau, Justine Lequesne, et al.. (2018). A new methodology to derive 3D kinetic parametric FDG PET images based on a mathematical approach integrating an error model of measurement. EJNMMI Research. 8(1). 99–99. 1 indexed citations
20.
Thureau, S., Marie-Hélène Vieillard, S. Supiot, & Lagrange Jl. (2016). Radiothérapie des métastases osseuses. Cancer/Radiothérapie. 20. S227–S234. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026